Zoledronic acid prevents bone loss in early-stage breast cancer

被引：0
|
作者：
Francesco Bertoldo
Giuseppe Tonini
Bruno Vincenzi
Daniele Santini
机构：
[1] University of Verona,
[2] University Campus Bio-Medico,undefined
来源：
Nature Reviews Clinical Oncology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Zoledronic acid is effective in the prevention of bone loss in premenopausal women with breast cancer being treated with endocrine therapy. The benefit of zoledronic acid probably extends for some years after cessation of therapy.
引用
收藏
页码：191 / 192
页数：1
相关论文
共 50 条
  • [1] Zoledronic acid prevents bone loss in early-stage breast cancer
    Bertoldo, Francesco
    Tonini, Giuseppe
    Vincenzi, Bruno
    Santini, Daniele
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (04) : 191 - 192
  • [2] Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer
    Hershman, Dawn L.
    McMahon, Donald J.
    Crew, Katherine D.
    Cremers, Serge
    Irani, Dinaz
    Cucchiara, Gina
    Brafman, Lois
    Shane, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4739 - 4745
  • [3] Zoledronic acid in early-stage breast cancer
    Normanno, Nicola
    De Luca, Antonella
    Gallo, Marianna
    Lamura, Luana
    Perrone, Francesco
    [J]. LANCET ONCOLOGY, 2011, 12 (11): : 991 - 991
  • [4] Routine Use of Zoledronic Acid in Early-Stage Breast Cancer
    Harnden, Kathleen
    Blackwell, Kimberly
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (04): : 480 - 486
  • [5] Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early stage breast cancer.
    Hershman D L
    McMahon D
    Crew K
    Cremers S
    Irani D
    Cucchiara G
    Brafman L
    Siarra A
    Shane E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S38 - S38
  • [6] Zoledronic acid is being investigated for the prevention of bone metastases in patients with early-stage breast cancer
    Coleman, R
    Gralow, J
    Bell, R
    Lipton, A
    [J]. BONE, 2004, 34 : S85 - S85
  • [7] Zoledronic acid may reduce early-stage breast cancer relapse
    不详
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (07) : 1019 - 1019
  • [8] Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
    Gnant, Michael
    [J]. CURRENT ONCOLOGY REPORTS, 2012, 14 (01) : 35 - 43
  • [9] Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
    Michael Gnant
    [J]. Current Oncology Reports, 2012, 14 : 35 - 43
  • [10] Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with early-stage breast cancer
    Coleman, Robert E.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (02): : 72 - 73
12345